Protostemonine attenuates alternatively activated macrophage and DRA-induced asthmatic inflammation
Protostemonine attenuates alternatively activated macrophage and DRA-induced asthmatic inflammation
复制标题
原百部碱可减轻交替激活的巨噬细胞和 DRA 诱导的哮喘炎症
DOI:
10.1016/j.bcp.2018.07.003
复制
发表时间:
2018-09-01
影响因子:
5.8
通讯作者:
Qian, Feng
中科院分区:
文献类型:
--
作者:
Song, Yunduan;Wu, Yaxian;Qian, Feng
Asthma is one of the most common pulmonary diseases that threatens human life because of lack of effective medicines. Protostemonine (PSN), an active alkaloid extracted from the roots of Stemona sesslifolia, has anti-inflammatory effects on acute lung injury and acute liver failure. However, it has not been defined whether PSN alleviates asthmatic inflammation. Here, we reported that PSN inhibits pulmonary eosinophil infiltration, goblet cell hyperplasia, mucus secretion, IgE and Th2 cytokine (IL-4, IL-5, IL-13 and IL-33) production by using DRA (dust mites, ragweed and aspergillus)-induced murine asthma model. Moreover, PSN also attenuated the expression of Arginase-1 (Arg-1), Ym-1 and Fizz-1, markers of AAM (alternatively activated macrophage) polarization, in lung tissues. In addition, PSN attenuated IL-4-induced expression of Arg-1, Ym-1 and Fizz-1 in bone marrow derived macrophages (BMDMs). Treatment with PSN decreased IL-4-induced STAT6 phosphorylation, KLF4 and IRF4 expression in BMDMs. Collectively, our results indicated that PSN ameliorates AAM polarization and asthmatic inflammation and might be a potential agent for treating asthma.